Below, meaningful Zepbound data were not available to graph: For the time being, Novo Nordisks Ozempic remains the dominant GLP-1 product with $4.20 billion in Q2 sales, outpacing its nearest competitor, Lillys Mounjaro, by more than $1 billion
It tends to look like reduced resilience across the board: slower recovery, less bandwidth, a body working harder to maintain the same ground
336 The cholesterol metabolite 27-HC, a selective estrogen receptor modulator and LXR agonist, promotes cancer metastasis and contributes to the growth of ER + breast tumors by acting directly on neutrophils and indirectly on -T cells, as well as by enhancing the resistance of metastatic cells to ferroptosis
00:09:24 Steve Small: Yep, thats a really good call out here and use our Treatment and Prevention of Hair Loss chart for a list of possible options to think about
These are all clues that your thyroid might need more attention